DD241071A5 - Verfahren zur herstellung eines salzes von dobutamin - Google Patents
Verfahren zur herstellung eines salzes von dobutamin Download PDFInfo
- Publication number
- DD241071A5 DD241071A5 DD85284649A DD28464985A DD241071A5 DD 241071 A5 DD241071 A5 DD 241071A5 DD 85284649 A DD85284649 A DD 85284649A DD 28464985 A DD28464985 A DD 28464985A DD 241071 A5 DD241071 A5 DD 241071A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- dobutamine
- acid
- salt
- water
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/285—Polyhydroxy dicarboxylic acids having five or more carbon atoms, e.g. saccharic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Detergent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68440484A | 1984-12-20 | 1984-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD241071A5 true DD241071A5 (de) | 1986-11-26 |
Family
ID=24747892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD85284649A DD241071A5 (de) | 1984-12-20 | 1985-12-18 | Verfahren zur herstellung eines salzes von dobutamin |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0187019B1 (pl) |
JP (1) | JPS61155355A (pl) |
KR (1) | KR870000803B1 (pl) |
CN (1) | CN1009922B (pl) |
AT (1) | ATE58370T1 (pl) |
AU (1) | AU589929B2 (pl) |
CA (1) | CA1254909A (pl) |
CS (1) | CS253734B2 (pl) |
DD (1) | DD241071A5 (pl) |
DE (2) | DE3580575D1 (pl) |
DK (1) | DK589385A (pl) |
EG (1) | EG17889A (pl) |
ES (2) | ES8705841A1 (pl) |
FI (1) | FI855018A (pl) |
GR (1) | GR853027B (pl) |
HU (1) | HU194805B (pl) |
MY (1) | MY104814A (pl) |
NZ (1) | NZ214583A (pl) |
PH (1) | PH22547A (pl) |
PL (1) | PL148296B1 (pl) |
PT (1) | PT81705B (pl) |
RO (1) | RO93391B (pl) |
SU (1) | SU1480761A3 (pl) |
ZA (1) | ZA859629B (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA881076B (en) * | 1987-02-24 | 1989-10-25 | Lilly Co Eli | Dobutamine salts |
FR2740337B1 (fr) * | 1995-10-27 | 1997-11-21 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique |
FR2740338B1 (fr) * | 1995-12-01 | 1997-12-05 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees contenant de la dobutamine |
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
CN105906515B (zh) * | 2015-12-10 | 2018-03-13 | 菏泽市方明制药有限公司 | 一种盐酸多巴酚丁胺脱色工艺 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987200A (en) * | 1972-04-12 | 1976-10-19 | Eli Lilly And Company | Method for increasing cardiac contractility |
FR2333499A1 (fr) * | 1975-12-01 | 1977-07-01 | Roussel Uclaf | Nouveau derive de la phenethylamine et ses sels, procede de preparation et application a titre de medicament |
-
1985
- 1985-12-16 RO RO121165A patent/RO93391B/ro unknown
- 1985-12-17 FI FI855018A patent/FI855018A/fi not_active Application Discontinuation
- 1985-12-17 NZ NZ214583A patent/NZ214583A/xx unknown
- 1985-12-17 PL PL1985256848A patent/PL148296B1/pl unknown
- 1985-12-17 ZA ZA859629A patent/ZA859629B/xx unknown
- 1985-12-17 GR GR853027A patent/GR853027B/el unknown
- 1985-12-18 DK DK589385A patent/DK589385A/da not_active Application Discontinuation
- 1985-12-18 SU SU853995134A patent/SU1480761A3/ru active
- 1985-12-18 CA CA000497954A patent/CA1254909A/en not_active Expired
- 1985-12-18 AT AT85309216T patent/ATE58370T1/de not_active IP Right Cessation
- 1985-12-18 AU AU51415/85A patent/AU589929B2/en not_active Ceased
- 1985-12-18 DE DE8585309216T patent/DE3580575D1/de not_active Expired - Lifetime
- 1985-12-18 PH PH33213A patent/PH22547A/en unknown
- 1985-12-18 EP EP85309216A patent/EP0187019B1/en not_active Expired - Lifetime
- 1985-12-18 CS CS859449A patent/CS253734B2/cs unknown
- 1985-12-18 KR KR1019850009534A patent/KR870000803B1/ko not_active IP Right Cessation
- 1985-12-18 DE DE198585309216T patent/DE187019T1/de active Pending
- 1985-12-18 DD DD85284649A patent/DD241071A5/de not_active IP Right Cessation
- 1985-12-18 EG EG809/85A patent/EG17889A/xx active
- 1985-12-18 PT PT81705A patent/PT81705B/pt not_active IP Right Cessation
- 1985-12-19 JP JP60287570A patent/JPS61155355A/ja active Granted
- 1985-12-19 ES ES550151A patent/ES8705841A1/es not_active Expired
- 1985-12-19 CN CN85109229A patent/CN1009922B/zh not_active Expired
- 1985-12-19 HU HU854878A patent/HU194805B/hu not_active IP Right Cessation
-
1987
- 1987-02-26 ES ES557426A patent/ES8802570A1/es not_active Expired
- 1987-10-08 MY MYPI87002873A patent/MY104814A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2607620C2 (de) | 4-Amino-5-hexensäure und Verfahren zu deren Herstellung | |
DE2240257C3 (de) | Verfahren zur Herstellung eines optisch aktiven Alkylchrysanthemats | |
DE2339888A1 (de) | Biologisch abbaubare sequestrantverbindung | |
DE2524059A1 (de) | Kontrastmittel fuer roentgenaufnahmen | |
DE2219635A1 (de) | Insulinprodukt | |
DE2734622C2 (pl) | ||
DD241071A5 (de) | Verfahren zur herstellung eines salzes von dobutamin | |
DE2725246C2 (pl) | ||
DE1770408A1 (de) | Links-1-n-Butyl-2',6'-Pipecoloxylidid und Verfahren zu seiner Herstellung | |
DE3044736C2 (pl) | ||
DE830994C (de) | Verfahren zur Herstellung von Doppelsalzen des Streptomycins | |
DE951567C (de) | Verfahren zur Herstellung von Antibiotikappantothenaten | |
DE1227893B (de) | Verfahren zur Herstellung von Glycyrrhetinsaeurederivaten | |
DE3390129C2 (de) | Verfahren zur Herstellung von kristallinem Dl-Cystein | |
DE902300C (de) | Verfahren zur Herstellung eines therapeutisch wirksamen 17-Oxycorticosteronesters | |
DE1016704B (de) | Verfahren zur Abtrennung von Tetracyclin aus seinen Gemischen mit Chlortetracyclin | |
DE1216280B (de) | Verfahren zur Herstellung der N-Alkansulfon-oder N-Alkansulfinsaeuren von Neomycin, Framycetin, Dihydrostreptomycin oder Kanamycin | |
DE2855945A1 (de) | Racemisierungsverfahren des d- (bzw. 1-)-tetramisols und entsprechendes erzeugnis | |
DE2044680A1 (de) | Verfahren zur Racemisierung von optisch aktivem Ammonium N acetyl alpha aminophenyl acetat | |
DE853794C (de) | Verfahren zur Herstellung von Penicillinverbindungen mit verlaengerter Wirkung | |
AT216141B (de) | Verfahren zur Herstellung des neuen Dihydrates des Calciumsalzes von Phenoxymethylpenicillin | |
DE3343725C2 (pl) | ||
AT356274B (de) | Verfahren zur herstellung von festem 6-(d-alpha -amino-p-hydroxyphenyl- acetamido)-penicillansaeurenatriumsalz | |
AT220613B (de) | Verfahren zur Herstellung des neuen 2-[1',1'-Diphenyl-propyl-(3')-amino]-3-phenyl-propan-gluconats | |
DE114974C (pl) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |